Evidence map›Paper›PMID 41933419›Full record

ReviewBiotechnology for biofuels and bioproducts2026

Flavin-dependent monooxygenases as versatile biocatalysts in biomanufacturing: mechanisms, engineering, and applications.

Yong Li, Ling Zhao, Xin Pu, Biao Geng, Wei Liu, Jie Gao, Xiaowei Peng, Yejun Han

Abstract readReview
In one paragraph

Review in Biotechnology for biofuels and bioproducts, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Surveying aIranian journal of microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yong Li *State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
Ling Zhao *State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
Xin PuState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
Biao GengState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
Wei LiuNational Engineering Research Center for Cultivated Land Protection, Sinochem Agriculture Linyi R&D Center, Linyi, 276024, China.
Jie GaoDepartment of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Xiaowei PengState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China.
Yejun HanState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, People's Republic of China. yjhan@ipe.ac.cn.

Funding

National Natural Science Foundation of China 32170093
6 · The paper itself

Abstract

Flavin-dependent monooxygenases (FMOs) are versatile oxidative biocatalysts that catalyze a wide array of oxygenation reactions, such as hydroxylation, epoxidation, Baeyer-Villiger oxidation, and halogenation. These enzymes utilize flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) as cofactors to mediate selective incorporation of oxygen into diverse substrates. Owing to their remarkable chemo-, regio-, and stereoselectivity, FMOs have attracted increasing attention as powerful tools for biomanufacturing. Recent advances in enzyme engineering, structural biology, and computational design have expanded the catalytic diversity of FMOs and enabled their integration into biocatalysis frameworks. Moreover, developments in cofactor regeneration, directed evolution, and cell-free biotransformation have improved FMOs' catalytic efficiency and scalability. Despite these advances, challenges such as limited thermostability, oxygen transfer efficiency, and substrate scope remain obstacles for industrial applications of FMOs. This review summarizes the structural characteristics, catalytic mechanisms, and engineering strategies of FMOs, highlights recent progress in their integration into biocatalysis platforms, and discusses current limitations and possible solutions. Insights into improving FMO catalytic performance and expanding their potential as next-generation biocatalysts for biosynthesis will be provided.

Indexed as

BiocatalysisBiosynthesisCofactor regenerationFlavin-dependent monooxygenaseNatural products

Identifiers

PMID41933419
PMCPMC13173928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.